The US Food and Drug Administration (FDA) will approve a booster dose for adolescents aged 12-15 in early 2022.
The report was published by The New York Times, citing sources.
The agency will make a decision next week, on January 3. In addition, doctors plan to allow the use of a booster dose of the vaccine for immunocompromised children aged 5-11 years.
According to the Centers for Disease Control and Prevention (CDC), which tracks COVID-19 vaccine statistics in the United States, about 1.8 million adolescents between the ages of 12 and 15 have been infected with the coronavirus since the beginning of the pandemic, and 246 of them have died.
In all, more than 53.7 million people in the United States have been infected with the coronavirus, and the death toll has exceeded 821,000. The country continues to rank first in the world on these two indicators.